Polymorphisms in dopamine transporter (SLC6A3) are associated with stimulant effects of d-amphetamine: An exploratory pharmacogenetic study using healthy volunteers

Behavior Genetics

Volumn 40, Issue 2, 2010, Pages 255-261

  Hamidovic, Ajna ^a   Dlugos, Andrea ^a   Palmer, Abraham A ^a   De Wit, Harriet ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

ADHD; Amphetamine; DAT1; Dopamine transporter; Rs460000; Rs463379; SLC6A3; Stimulant response

Indexed keywords

ALANINE; CYSTEINE; DEXAMPHETAMINE; DOPAMINE TRANSPORTER; DOPAMINE TRANSPORTER SLC6A3; PLACEBO; UNCLASSIFIED DRUG;

ADULT; AREA UNDER THE CURVE; ARTICLE; ATTENTION DEFICIT DISORDER; BLOOD PRESSURE; CARDIOVASCULAR RESPONSE; CAUCASIAN; COGNITION; DRUG EFFICACY; EUPHORIA; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HEART RATE; HUMAN; HUMAN EXPERIMENT; MALE; MOOD; NERVE STIMULATION; NORMAL HUMAN; PHARMACOGENETICS; PLEIOTROPY; SELF REPORT; SINGLE NUCLEOTIDE POLYMORPHISM; TASK PERFORMANCE;

ADOLESCENT; ADULT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CROSS-OVER STUDIES; DEXTROAMPHETAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DOUBLE-BLIND METHOD; FEMALE; GENOTYPE; HUMANS; MALE; PHARMACOGENETICS; PLACEBOS; POLYMORPHISM, GENETIC; YOUNG ADULT;

EID: 77949265506     PISSN: 00018244     EISSN: 15733297     Source Type: Journal    
DOI: 10.1007/s10519-009-9331-7     Document Type: Article

References (41)

1. SC Bakker EM van der Meulen N Oteman H Schelleman PL Pearson JK Buitelaar, et al. 2005 DAT1, DRD4, and DRD5 polymorphisms are not associated with ADHD in Dutch families Am J Med Genet B Neuropsychiatr Genet 132 50 52
2. J Bergman BK Madras SE Johnson RD Spealman 1989 Effects of cocaine and related drugs in nonhumans primates. III. Self-administration by squirrel monkeys J Pharmacol Exp Ther 251 150 155 2529365
3. LH Brauer H de Wit 1996 Subjective responses to d-amphetamine alone and after pimozide pretreatment in normal, healthy volunteers Biol Psychiatry 39 26 32 10.1016/0006-3223(95)00110-7 8719123 (Pubitemid 26024199)
4. J Broadbent EK Michael EE Riddle JB Appel 1991 Involvement of dopamine uptake in the discriminative stimulus effects of cocaine Behav Pharmacol 2 187 197 10.1097/00008877-199106000-00002 11224062
5. K Brookes X Xu W Chen K Zhou B Neale N Lowe, et al. 2006 The analysis of 51 genes in DSM-IV combined type attention deficit hyperactivity disorder: association signals in DRD4, DAT1 and 16 other genes Mol Psychiatry 11 934 953 10.1038/sj.mp.4001869 16894395 (Pubitemid 44470216)
6. EH Cook Jr MA Stein MD Krasowski NJ Cox DM Olkon JE Kieffer, et al. 1995 Association of attention-deficit disorder and the dopamine transporter gene Am J Hum Genet 56 993 998 7717410
7. G Daly Z Hawi M Fitzgerald M Gill 1999 Mapping susceptibility loci in attention deficit hyperactivity disorder: preferential transmission of parental alleles at DAT1, DBH and DRD5 to affected children Mol Psychiatry 4 192 196 10.1038/sj.mp.4000510 10208453
8. C Davis RD Levitan AS Kaplan J Carter C Reid C Curtis, et al. 2007 Dopamine transporter (DAT1) associated with appetite suppression to methylphenidate in a case-control study of binge eating disorder Neuropsychopharmacology 32 2199 2206 10.1038/sj.npp.1301348 17314918 (Pubitemid 47417697)
9. H de Wit EH Uhlenhuth CE Johanson 1986 Individual differences in the reinforcing and subjective effects of amphetamine and diazepam Drug Alcohol Depend 16 341 360 10.1016/0376-8716(86)90068-2 3698813 (Pubitemid 16168232)
10. Derogatis L (1983) SLC-90-R manual II. Clinical Psychometric Research, Towson
11. G Di Chiara A Imperato 1988 Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats Proc Natl Acad Sci USA 85 5274 5278 10.1073/pnas.85.14.5274 2899326 (Pubitemid 18192948)
12. Y Feng KG Wigg R Makkar A Ickowicz T Pathare R Tannock, et al. 2005 Sequence variation in the 30-untranslated region of the dopamine transporter gene and attention-deficit hyperactivity disorder (ADHD) Am J Med Genet B Neuropsychiatr Genet 139 1 6
13. MB First RL Spitzer M Gibbon JBW Williams 1995 The structured clinical interview for DSM-III-R personality disorders (SCID-II). Part I: Description J Pers Disord 9 2 83 91
14. S Friedel K Saar S Sauer A Dempfle S Walitza 2007 Association and linkage of allelic variants of the dopamine transporter gene in ADHD Mol Psychiatry 12 923 933 10.1038/sj.mp.4001986 17579611 (Pubitemid 47482693)
15. FH Gabbay 2003 Variations in affect following amphetamine and placebo: markers of stimulant drug preference Exp Clin Psychopharmacol 11 91 101 10.1037/1064-1297.11.1.91 12622347
16. C Hodgkinson Q Yuan K Xu P-H Shen E Heinz E Lobos, et al. 2008 Addictions biology: haplotype-based analysis for 130 candidate genes on a single array Alcohol Alcohol 43 5 505 515 18477577
17. SR Jones RR Gainetdinov RM Wightman MG Caron 1998 Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter J Neurosci 18 1979 1986 9482784
18. MJ Kuhar MC Ritz JW Boja 1991 The dopamine hypothesis of the reinforcing properties of cocaine Trends Neurosci 14 299 302 10.1016/0166-2236(91)90141-G 1719677
19. K Langley D Turic TR Peirce S Mills MB Van Den Bree MJ Owen, et al. 2005 No support for association between the dopamine transporter (DAT1) gene and ADHD Am J Med Genet B Neuropsychiatr Genet 139 7 10
20. J Lasky-Su J Biederman AE Doyle T Wilens M Monuteaux JW Smoller, et al. 2006 Family based association analysis of statistically derived quantitative traits for drug use in ADHD and the dopamine transporter gene Addict Behav 31 1088 1099 10.1016/j.addbeh.2006.03.013 16647218 (Pubitemid 43775964)
21. D Li PC Sham MJ Owen L He 2006 Meta-analysis shows significant association between dopamine system genes and attention deficit hyperactivity disorder (ADHD) Hum Mol Genet 15 2276 2284 10.1093/hmg/ddl152 16774975 (Pubitemid 43994869)
22. D Lott S Kim E Cook H de Wit 2005 Dopamine transporter gene associated with diminished subjective response to amphetamine Neuropsychopharmacology 30 602 609 10.1038/sj.npp.1300637 15602501 (Pubitemid 40271162)
23. WR Martin JW Sloan JD Sapira DR Jasinski 1971 Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man Clin Pharmacol Ther 12 245 258 5554941
24. JN Matthews DG Altman MJ Campbell P Royston 1990 Analysis of serial measurements in medical research BMJ 300 6719 230 235 10.1136/bmj.300.6719.230 2106931 (Pubitemid 20045528)
25. MM Mitler R Hajdukovic MK Erman 1993 Treatment of narcolepsy with methamphetamine Sleep 16 306 317 8341891
26. AJ Parkin RI Java 1999 Deterioration of frontal lobe function in normal aging: Influences of fluid intelligence versus perceptual speed Neuropsychology 13 539 545 10.1037/0894-4105.13.4.539 10527062 (Pubitemid 29474642)
27. JK Pritchard M Stephens P Donnelly 2000 Inference of population structure using multilocus genotype data Genetics 155 945 959 10835412
28. D Purper-Ouakil M Wohl MC Mouren P Verpillat J Ades P Gorwood 2005 Meta-analysis of family-based association studies between the dopamine transporter gene and attention deficithyperactivity disorder Psychiatr Genet 15 53 59 10.1097/00041444-200503000-00009 15722958 (Pubitemid 40411571)
29. MC Ritz RJ Lamb SR Goldberg MJ Kuhar 1987 Cocaine receptors on dopamine transporters are related to self-administration of cocaine Science 237 1219 1223 10.1126/science.2820058 2820058
30. WK Schiffer JS Fowler DL Alexoff J Logan SC Dewey 2006 Therapeutic doses of amphetamine or methylphenidate differentially increase synaptic and extracellular dopamine. Therapeutic doses of amphetamine or methylphenidate differentially increase synaptic and extracellular dopamine Synapse 59 243 251 10.1002/syn.20235 16385551 (Pubitemid 43202592)
31. ML Selzer 1971 The Michigan alcoholism screening test: the quest for a new diagnostic 575 instrument Am J Psychiatr 127 1653 1658 5565851
32. T Spencer J Biederman T Wilens M Harding D O'Donnell S Griffin 1996 Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle J Am Acad Child Adolesc Psychiatry 35 409 432 8919704
33. C Spielewoy G Biala C Roubert M Hamon C Betancur B Giros 2001 Hypolocomotor effects of acute and daily d-amphetamine in mice lacking the dopamine transporter Psychopharmacology (Berl) 159 2 9 10.1007/s002130100901
34. ME Talkowski G Kirov M Bamne L Georgieva G Torres 2008 A network of dopaminergic gene variations implicated as risk factors for schizophrenia Hum Mol Genet 17 5 747 758 10.1093/hmg/ddm347 18045777 (Pubitemid 351292263)
35. J Vilkki P Holst 1991 Mental programming after frontal lobe lesions: results on digit symbol performance with self-selected goals Cortex 27 203 211 1879149
36. ND Volkow GJ Wang MW Fischman RW Foltin JS Fowler MN Abumrad, et al. 1997 Relationship between subjective effects of cocaine and dopamine transporter occupancy Nature 386 827 830 10.1038/386827a0 9126740
37. ND Volkow JS Fowler GJ Wang JM Swanson 2004 Dopamine in drug abuse and addiction: results from imaging studies and treatment implications Mol Psychiatry 9 557 569 10.1038/sj.mp.4001507 15098002 (Pubitemid 38850435)
38. ID Waldman DC Rowe A Abramowitz ST Kozel JH Mohr SL Sherman, et al. 1998 Association and linkage of the dopamine transporter gene and attention-deficit hyperactivity disorder in children: heterogeneity owing to diagnostic subtype and severity Am J Hum Genet 63 1767 1776 10.1086/302132 9837830 (Pubitemid 30415740)
39. Wechsler D (1958) The measure and appraisal of adult intelligence. Williams and Wilkins, Baltimore
40. T White JusticeA JH H de Wit 2002 Differential subjective effects of d-amphetamine by gender, hormone levels and menstrual cycle phase Pharmacol Biochem Behav 73 729 741 10.1016/S0091-3057(02)00818-3 12213517 (Pubitemid 35251831)
41. RA Wise MA Bozarth 1987 A psychomotor stimulant theory of addiction Psychol Rev 94 469 492 10.1037/0033-295X.94.4.469 3317472